Tourmaline Bio (TRML) Misses Q2 EPS by 90c
Tweet
Share
E-mailGet Alerts TRML Hot Sheet
Join SI Premium – FREE
Tourmaline Bio (NASDAQ: TRML) reported Q2 EPS of ($0.90).
For earnings history and earnings-related data on Tourmaline Bio (TRML) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- Kotak Downgrades Dixon Technologies India Ltd (DIXON:IN) to Add (2)
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
